These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8174793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Considerations in performing virus spiking experiments and process validation studies.
    Darling AJ.
    Dev Biol Stand; 1993; 81():221-9. PubMed ID: 8174806
    [Abstract] [Full Text] [Related]

  • 6. EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Jul; 19(3):247-51. PubMed ID: 1954007
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Process scale considerations in evaluation studies and scale-up.
    Walter JK, Werz W, Berthold W.
    Dev Biol Stand; 1996 Jul; 88():99-108. PubMed ID: 9119169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chromatographic removal of viruses from plasma derivatives.
    Burnouf T.
    Dev Biol Stand; 1993 Jul; 81():199-209. PubMed ID: 8174804
    [Abstract] [Full Text] [Related]

  • 13. Strategies for the validation of viral inactivation in biologic products.
    Aronson DL.
    Prog Clin Biol Res; 1990 Jul; 324():137-49. PubMed ID: 2408050
    [No Abstract] [Full Text] [Related]

  • 14. Viral safety of biological products and the concept of validation.
    Horaud F.
    Dev Biol Stand; 1996 Jul; 88():19-24. PubMed ID: 9119135
    [No Abstract] [Full Text] [Related]

  • 15. Virological issues in the use of cell therapies.
    Minor PD.
    Dev Biol (Basel); 2004 Jul; 118():151-3. PubMed ID: 15645685
    [Abstract] [Full Text] [Related]

  • 16. Affinity chromatography to remove viruses during preparation of plasma derivatives.
    Lawrence JE.
    Dev Biol Stand; 1993 Jul; 81():191-7. PubMed ID: 8174803
    [Abstract] [Full Text] [Related]

  • 17. Qualification of virus/cell systems for their intended use.
    Gröner A.
    Dev Biol (Basel); 2004 Jul; 118():55-63. PubMed ID: 15645673
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.